公开(公告)号：US20230310427A1

公开(公告)日：2023-10-05

申请号：US18003733

申请日：2021-06-30

Applicant: UNIVERSITY OF SOUTH AUSTRALIA

Inventor： Richard John HEAD ,  Shudong WANG ,  Md Saiful ISLAM ,  Malika KUMARASIRI

IPC: A61K31/505 ,  A61P35/00 ,  A61K31/337 ,  A61P15/08 ,  A61P13/08 ,  A61P35/02

CPC classification number: A61K31/505 ,  A61K31/337 ,  A61P13/08 ,  A61P15/08 ,  A61P35/00 ,  A61P35/02

Abstract: Methods and uses of Rilpivirine and analogues thereof in the treatment and/or prevention of proliferative cell diseases and conditions are disclosed. Among the diseases and conditions that may be treated and/or prevented, are cancers characterised by Aurora A dysregulation.